TGF-β1-induced CTGF expression, activity and secretion were reduced by inhibiting Ras and MEK activation in human proximal tubular epithelial cells [109], thus suggesting that inhibiting Ras/MEK/ERK signaling pathways could be a therapeutic strategy in renal fibrosis. This evidence concerns the gene MAPK1 and renal fibrosis.